Regular Member

Principal Investigator Training

• Ph.D., Université de Montréal, 2011

• Postdoctoral Researcher, Massachusetts Institute of Technology, 2011–2015

  
  

Laboratory Name

Laboratory of Nanopharmacology and Pharmaceutical Nanoscience

Affiliated Department

Faculty of Pharmacy

Other Affiliations

• Endocrinology and Nephrology Research Axis – Centre de recherche du CHU de Québec – Université Laval

  
  

Funding Agencies

• Natural Sciences and Engineering Research Council of Canada (NSERC)

• Canada Foundation for Innovation (CFI)

• John R. Evans Leaders Fund (JELF)

• Fonds de recherche du Québec – Santé (FRQS)

  
  

Laboratory Research

We develop and characterize technological platforms aimed at improving the efficacy and safety of pharmaceutical active ingredients. Our research focuses on the development of nanomaterials and biomaterials and on studying their interactions with their environment. Our research activities cover polymer chemistry, nanomaterial preparation, and the characterization of their fate in the bloodstream using several animal models.

Areas of Expertise

• Nanomedicine

• Drug delivery

• Physicochemical formulation

• Pharmacokinetics and nanopharmacology

  
  

Teaching

• PHA-1015 — Pharmaceutical Technology

• PHA-1022 — Drugs for the Nervous and Musculoskeletal Systems I

• PHA-1023 — Drugs for the Digestive System I

• PHA-2071 — Introduction to Pharmacogenomics and Pharmaceutical Biotechnology

• PHA-7057 — Introduction to Nanopharmacology and Theranostics

  
  

Research and Development (R&D) Services

• Pharmaceutical formulation development

• Pharmacokinetic and biodistribution studies

  
  

Industrial Research Collaborations

• 2016–Present: Ovensa Inc.